Category: Leukemia
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions Contact Us Summary A tailored cancer vaccine was generated in this study, in which patient-derived acute myeloid leukemia (AML) cells were fused with autologous dendritic cells, resulting in a hybridoma that potently stimulated wide antitumor responses. The results […]
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy Contact Us Summary The study investigates how patients with GBM responded to cervical intranodal immunization with autologous tumour lysate-loaded dendritic cells (DCs) after radiation treatment and TMZ. The findings imply that DC immunization in patients […]
Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy
Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy Contact Us Summary This study investigated the efficiency of dendritic cell-activated and cytokine-induced killer cell (DC-CIK) therapy on children with acute myeloid leukemia (AML) after chemotherapy was investigated. The results conclude, MRD in children with AML can […]
Vaccination of Diffuse Large B- Cell Lymphoma Patients with Antigen-Primed Dendritic Cells
Vaccination of Diffuse Large B- Cell Lymphoma Patients with Antigen-Primed Dendritic Cells Contact Us Summary This study investigates the generation of monocyte-derived dendritic cells of lymphoma patient’s peripheral blood mononuclear cells then; these cells were used as vaccine. The results conclude that the use of dendritic cell probably is one of the suitable noninvasive treatments […]
Autologous Dendritic Cells Combined with Cytokine-induced Killer Cells Synergize Low-dose Chemotherapy in Elderly Patients with Acute Myeloid Leuakemia
Autologous Dendritic Cells Combined with Cytokine-induced Killer Cells Synergize Low-dose Chemotherapy in Elderly Patients with Acute Myeloid Leuakemia Contact Us Summary The goal of the study is to see if it’s possible to culture dendritic cells (DCs) and cytokine-induced killer (CIK) cells obtained at the time of an initial diagnosis of AML in elderly patients, […]
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients Contact Us Summary In this study, autologous leukemic apoptotic corpse-pulsed dendritic cells (DC) are used to investigate the feasibility of a vaccination in patients with acute myeloid leukemia (AML). There were no significant adverse events reported as a result […]
Successful alternative treatment for relapsed adult Acute Lymphoblastic Leukemia with Dendritic Cells- Cytokine-Induced Killer Cells combined with a rituximab-based regimen
Successful alternative treatment for relapsed adult Acute Lymphoblastic Leukemia with Dendritic Cells- Cytokine-Induced Killer Cells combined with a rituximab-based regimen Contact Us Summary This study investigates the efficacy and safety of DC-CIK for patients with Acute lymphoblastic leukemia (ALL) that are unable to tolerate chemotherapy. The results suggests , relapsed ALL was successfully treated with […]
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia Contact Us Summary This study investigates the effect of dendritic cells (DCs) electroporated with Wilms’ tumor 1 (WT1) messenger RNA (mRNA) as postremission treatment for patients with acute myeloid leukemia (AML) . The findings suggest the treatment is an effective […]
Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia
Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia Tumour shrinking with DCT Contact Us Summary In the current study, the authors evaluated the therapeutic potential of human telomerase reverse transcriptase (hTERT)-expressing autologous dendritic cells (hTERT-DCs) in patients with acute myeloid leukemia (AML). The hTERT-DCs were […]
A novel allogeneic off-the-shelf Dendritic Cell Vaccine for post- remission treatment of elderly patients with Acute Myeloid Leukemia
A novel allogeneic off-the-shelf Dendritic Cell Vaccine for post- remission treatment of elderly patients with Acute Myeloid Leukemia Tumour shrinking with DCT Contact Us Summary The options for Patients with acute myeloid leukemia (AML) are linked with high comorbidity rates and poor survival. Dendritic Cell Therapy (DCT) is a promising alternative treatment. The Dendritic cell […]
